Tenegl 20mg (Teneligliptin Hydrate)

Adult dose

The recommended dose for this medication is 20 mg once daily, whether used as monotherapy or in combination therapy. It can be taken regardless of meals.

This medication should not be administered to certain patients. For instance, those allergic to the active ingredient or any other component should not take it. Additionally, it is not suitable for patients with type 1 diabetes, diabetic ketoacidosis, or those in a comatose state. It is also not recommended for patients with severe infections or those who have undergone surgery or suffered serious trauma. Use caution when administering this medication to patients with severe liver dysfunction or heart failure. In particular, it is not recommended for patients with severe heart failure. Patients taking sulfonylureas or insulin should be cautious as there is a risk of hypoglycemia. Exercise caution in patients at a high risk of hypoglycemia, such as those with pituitary or adrenal insufficiency, malnutrition, irregular eating habits, intense exercise, and excessive alcohol consumption. Individuals with a history of abdominal surgery or bowel obstruction should also exercise caution when taking this medication. Patients with arrhythmias or heart diseases that can affect heart rhythm, as well as those with hypokalemia, should be careful as QT interval prolongation may occur. Acute pancreatitis symptoms may arise, so if persistent abdominal pain or vomiting occurs, an immediate medical evaluation should be sought. During treatment with this medication, symptoms of hypoglycemia may appear; thus, if symptoms occur, foods containing sugar should be consumed. Caution is particularly needed when taken with other diabetic medications as the risk of hypoglycemia increases. Reported side effects include constipation, abdominal bloating, abdominal pain, liver function abnormalities, interstitial pneumonia, skin rash or itching, and acute pancreatitis. Pregnant or breastfeeding women are advised against taking this medication, and a consultation with a physician is required for decisions during breastfeeding. The safety in pediatric patients has not been established, and elderly patients may have diminished physical function, hence they should be closely monitored during treatment. In cases of overdose, symptoms should be closely monitored and appropriate treatment should be administered as necessary. Caution is advised as the risk of hypoglycemia may increase when used with insulin or sulfonylureas. Furthermore, there may be interactions with other medications, so patients should always consult with their physician or pharmacist regarding the medications they are taking. If any unusual symptoms such as hypoglycemia, skin rash, severe joint pain, or persistent abdominal pain occur while taking this medication, immediate notification and consultation with healthcare professionals are necessary.

Serious side effects

Hypoglycemia, bowel obstruction, liver dysfunction, interstitial pneumonia, bullous pemphigoid, acute pancreatitis, urticaria, severe swelling (edema), difficulty breathing, chest tightness, liver issues (jaundice), severe neurological symptoms, significant edema or urinary abnormalities, respiratory issues

Mild side effects

• Dizziness
• constipation
• abdominal bloating
• abdominal discomfort
• nausea
• abdominal pain
• flatulence
• stomatitis
• gastric polyps
• colon polyps

This medication should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 60 tablets/bottle